Product NDC: | 0002-1407 |
Proprietary Name: | Quinidine Gluconate |
Non Proprietary Name: | Quinidine Gluconate |
Active Ingredient(s): | 80 mg/mL & nbsp; Quinidine Gluconate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0002-1407 |
Labeler Name: | Eli Lilly and Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA007529 |
Marketing Category: | NDA |
Start Marketing Date: | 19510301 |
Package NDC: | 0002-1407-01 |
Package Description: | 10 mL in 1 VIAL (0002-1407-01) |
NDC Code | 0002-1407-01 |
Proprietary Name | Quinidine Gluconate |
Package Description | 10 mL in 1 VIAL (0002-1407-01) |
Product NDC | 0002-1407 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Quinidine Gluconate |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19510301 |
Marketing Category Name | NDA |
Labeler Name | Eli Lilly and Company |
Substance Name | QUINIDINE GLUCONATE |
Strength Number | 80 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA] |